September 2012 | OncologyLive

Conference Offers "Deep Dive" Into Managing Clinical Issues

October 22, 2012

A thorough examination of emerging strategies for the treatment of breast cancer, as well as the clinical data underlying new and existing options, will form the cornerstone of the 9th Annual School of Breast Oncology.

Tackling Questions on Genetic Testing

October 19, 2012

The expansion of testing for genetic abnormalities in patients with advanced lung cancer is generating questions about which patients' tumors should be tested, how they should be tested, and whether they should be retested.

Putting the Genome to Work in Breast Cancer

October 18, 2012

An interview with Elaine R. Mardis, PhD, discussing the clinical applications of genomic research on the near horizon that will enable more personalized therapy for patients at earlier stages of breast cancer.

The MEK Junction: Protein Presents a Ripe Target for Inhibitors

October 11, 2012

Though located far downstream of the extracellular trigger that initiates its signaling pathway, the MEK protein is no less significant a player in the cascade of events that promotes key cellular processes.